<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">BELLADONNA TINCTURE</span><br/>(bell-a-don'na)<br/><b>Classifications:</b> <span class="classification">autonomic nervous system agent</span>; <span class="classification">anticholinergic (parasympatholytic)</span>; <span class="classification">antimuscarinic, antispasmodic</span><br/><b>Prototype: </b>Atropine<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>2733 mg/100 mL tincture</p>
<h1><a name="action">Actions</a></h1>
<p>Reversibly blocks action of acetylcholine at parasympathetic neuroeffector sites.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Belladonna inhibits smooth muscle contractions and suppresses secretions of secretory glands.</p>
<h1><a name="uses">Uses</a></h1>
<p>Adjunct in treatment of peptic ulcer disease, irritable bowel syndrome, and neurogenic bowel disturbances. Also has been used
         for dysmenorrhea, nocturnal enuresis, spasms of urinary tract, nausea and vomiting of pregnancy, vertigo, and for symptomatic
         relief of parkinsonism.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to anticholinergic drugs; obstructive uropathy, atony of urinary bladder; esophageal reflux, obstructive
         disease of GI tract, intestinal atony, paralytic ileus, severe ulcerative colitis, toxic megacolon; myasthenia gravis; narrow-angle
         glaucoma; unstable cardiovascular status in acute hemorrhages. Safety during pregnancy (category C), lactation, or in children
         is not established.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Autonomic neuropathy; heart disease, hypertension; patients &gt;40 y (higher incidence of glaucoma).</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Antispasmodic</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 0.61 mL t.i.d. or q.i.d.<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 0.1 mL/kg/d in 34 divided doses (max: 3.5 mL/d)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Administer 3060 min before meals and at bedtime.</li>
<li>Space administration of antacid and belladonna preparations at least 2 h apart.</li>
<li>Store at 15°30° C (59°86° F) in tightly covered, light-resistant containers, unless otherwise
            directed.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> All:</span> Dose related. <span class="typehead">CNS:</span> Excitement (young children and the older adults), confusion, delirium. <span class="typehead">CV:</span> Rapid heart beat, tachycardia, palpitation. <span class="typehead">Special Senses:</span> Blurred vision, mydriasis, photophobia. <span class="typehead">GI:</span>
<span class="speceff-common">Dry mouth, constipation.</span>
<span class="typehead">Urogenital:</span> Urinary retention, urgency. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Amantadine,</b>
<span class="classification">antihistamines</span>, <span class="classification">tricyclic antidepressants</span>, <b>quinidine, </b><b>disopyramide, </b><b>procainamide</b> have additive anticholinergic effects; <b>levodopa</b> effects decreased; <b>methotrimeprazine</b> may precipitate extrapyramidal effects; antipsychotic effects of <span class="classification">phenothiazines</span> decreased (decreased absorption). 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Readily absorbed from GI tract. <span class="typehead">Onset:</span> 12 h. <span class="typehead">Distribution:</span> Well distributed in body; crosses blood brain barrier. <span class="typehead">Elimination:</span> Excreted unchanged in urine. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor ambulation of older adults or debilitated patients carefully, since drug may cause drowsiness and confusion.</li>
<li>Monitor I&amp;O and assess for urinary retention.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>
            							Note: Increase in fluid intake and bulk in diet may prevent or relieve constipation. Notify physician if constipation persists.
            						
         </li>
<li>Avoid hot baths, saunas, and strenuous work or exercise during hot and humid weather.</li>
<li>Do not drive or engage in potentially hazardous activities until response to drug is known.</li>
<li>Practice meticulous oral hygiene. Sugarless gum, lemon drops, and frequent sips of water may help dry mouth.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>